{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:03:23Z","timestamp":1787069003901,"version":"build-2736575974"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T00:00:00Z","timestamp":1512432000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI 13\/00341"],"award-info":[{"award-number":["PI 13\/00341"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/00182"],"award-info":[{"award-number":["PI14\/00182"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministerio de Educaci\u00f3n y Ciencia","award":["PI14\/00182"],"award-info":[{"award-number":["PI14\/00182"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s12072-017-9833-y","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T06:52:19Z","timestamp":1512456739000},"page":"68-80","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Pharmacologic prevention of variceal bleeding and rebleeding"],"prefix":"10.1007","volume":"12","author":[{"given":"Anna","family":"Baiges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Hern\u00e1ndez-Gea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,5]]},"reference":[{"key":"9833_CR1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-2007-1007133","volume":"19","author":"G D\u2019Amico","year":"1999","unstructured":"D\u2019Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999;19:475\u2013505","journal-title":"Semin Liver Dis"},{"issue":"3","key":"9833_CR2","first-page":"743","volume":"63","author":"Franchis R De","year":"2015","unstructured":"De Franchis R, Faculty BV. Expanding consensus in portal hypertension. Report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol Eur Assoc Study Liver 2015;63(3):743\u2013752","journal-title":"J Hepatol Eur Assoc Study Liver"},{"issue":"5","key":"9833_CR3","first-page":"1082","volume":"54","author":"Franchis R De","year":"2011","unstructured":"De Franchis R, Faculty BV. Revising consensus in portal hypertension: report of the Baveno V Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol Eur Assoc Study Liver 2011;54(5):1082\u20131083","journal-title":"J Hepatol Eur Assoc Study Liver"},{"key":"9833_CR4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMra0901512","volume":"362","author":"G Garcia-Tsao","year":"2010","unstructured":"Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 2010;362:823\u2013832","journal-title":"N Engl J Med"},{"issue":"21","key":"9833_CR5","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","volume":"353","author":"RJ Groszmann","year":"2005","unstructured":"Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005;353(21):2254\u20132261","journal-title":"N Engl J Med"},{"issue":"S1","key":"9833_CR6","first-page":"S121","volume":"62","author":"J Bosch","year":"2015","unstructured":"Bosch J, Groszmann RJ, Shah VH. Evolution in the understanding of the pathophysiological basis of portal hypertension: how changes in paradigm are leading to successful new treatments. J Hepatol Eur Assoc Study Liver 2015;62(S1):S121\u2013S130","journal-title":"J Hepatol Eur Assoc Study Liver"},{"issue":"1","key":"9833_CR7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","volume":"44","author":"G D\u2019Amico","year":"2006","unstructured":"D\u2019Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44(1):217\u2013231","journal-title":"J Hepatol"},{"issue":"1","key":"9833_CR8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.28264","volume":"63","author":"C Villanueva","year":"2016","unstructured":"Villanueva C, Albillos A, Genesc\u00e0 J, Abraldes JG, Calleja JL, Aracil C, et al. Development of hyperdynamic circulation and response to beta-blockers in compensated cirrhosis with portal hypertension. Hepatology. 2016;63(1):197\u2013206","journal-title":"Hepatology"},{"issue":"2","key":"9833_CR9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","volume":"133","author":"C Ripoll","year":"2007","unstructured":"Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133(2):481\u2013488","journal-title":"Gastroenterology"},{"key":"9833_CR10","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0016-5085(96)70070-7","volume":"111","author":"J Bruix","year":"1996","unstructured":"Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients. Prognostic value of preoperative portal pressure. Gastroenterology. 1996;111:1018\u20131122","journal-title":"Gastroenterology"},{"key":"9833_CR11","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jhep.2009.01.014","volume":"50","author":"C Ripoll","year":"2009","unstructured":"Ripoll C, Groszmann R, Garcia-Tsao G, Bosch J, Grace N, Burroughs A, et al. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol 2009;50:923\u2013928","journal-title":"J Hepatol"},{"issue":"2","key":"9833_CR12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1148\/radiol.13121769","volume":"268","author":"JR Eisenbrey","year":"2013","unstructured":"Eisenbrey JR, Dave JK, Halldorsdottir VG, Merton DA, Miller C, Gonzalez JM, et al. Chronic liver disease: noninvasive subharmonic aided pressure estimation of hepatic venous pressure gradient. Radiology. 2013;268(2):581\u2013588","journal-title":"Radiology"},{"issue":"6","key":"9833_CR13","first-page":"1345","volume":"63","author":"RT Stravitz","year":"2015","unstructured":"Stravitz RT, Reuben A, Mizrahi M, Lalazar G, Brown K, Gordon SC, et al. Use of the methacetin breath test to classify the risk of cirrhotic complications and mortality in patients evaluated\/listed for liver transplantation. J Hepatol Eur Assoc Study Liver 2015;63(6):1345\u20131351","journal-title":"J Hepatol Eur Assoc Study Liver"},{"key":"9833_CR14","doi-asserted-by":"crossref","unstructured":"Berzigotti A, Seijo S, Arena U, Abraldes JG, Vizzutti F, Garc\u00eda-Pag\u00e1n JC, et al. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology 2013; 144(1):102.e1\u2013111.e1","DOI":"10.1053\/j.gastro.2012.10.001"},{"key":"9833_CR15","doi-asserted-by":"crossref","unstructured":"Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2017;65(1):310\u2013335","DOI":"10.1002\/hep.28906"},{"key":"9833_CR16","doi-asserted-by":"crossref","unstructured":"Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014; 383(9930): 1749\u20131761","DOI":"10.1016\/S0140-6736(14)60121-5"},{"key":"9833_CR17","unstructured":"Pagliaro L, D\u2019Amico G, Pasta L, Politi F, Vizzini G, Traina M, et al. Portal hypertension in cirrhosis: natural history. In: Bosch J, Groszmann RJ, editors. Portal Hypertension. Pathophysiology and Treatment. Oxford, UK: Blackwell Scientific;1994. pp. 72\u201392."},{"key":"9833_CR18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.gie.2006.08.023","volume":"65","author":"M Kovalak","year":"2007","unstructured":"Kovalak M, Lake J, Mattek N, Eisen G, Lieberman D, Zaman A. Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database. Gastrointest Endosc 2007;65:82\u201388.","journal-title":"Gastrointest Endosc"},{"key":"9833_CR19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0168-8278(02)00420-8","volume":"38","author":"M Merli","year":"2003","unstructured":"Merli M, Nicolini G, Angeloni S, Rinaldi V, De Santis A, Merkel C, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol 2003;38:266\u2013272","journal-title":"J Hepatol"},{"key":"9833_CR20","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198810133191505","volume":"319","author":"North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices","year":"1988","unstructured":"North Italian Endoscopic Club for the Study and Treatment of esophageal varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1988;319:983\u2013989","journal-title":"N Engl J Med"},{"issue":"6","key":"9833_CR21","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cgh.2014.11.019","volume":"13","author":"P Tandon","year":"2015","unstructured":"Tandon P, Abraldes J, Keough A, Bastiampillai R, Jakayumar S, Carbonneau M, et al. Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on Child\u2013Pugh class and effects of antibiotics. Clin Gastroenterol Hepatol 2015;13(6):1189\u20131196","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"9833_CR22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jhep.2007.10.008","volume":"48","author":"JG Abraldes","year":"2008","unstructured":"Abraldes JG, Villanueva C, Ba\u00f1ares R, Aracil C, Catalina MV, Garc\u00eda-Pag\u00e1n JC, et al. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol 2008;48(2):229\u2013236","journal-title":"J Hepatol"},{"key":"9833_CR23","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(03)12778-X","volume":"361","author":"J Bosch","year":"2003","unstructured":"Bosch J, Garc\u00eda-Pag\u00e1n J. Prevention of variceal rebleeding. Lancet 2003;361:952\u2013954","journal-title":"Lancet"},{"key":"9833_CR24","doi-asserted-by":"crossref","unstructured":"Everhart JE, Lok AS, Kim HY, Morgan TR, Lindsay KL, Chung RT, et al. Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial. Gastroenterology 2009;137(2):549\u2013557","DOI":"10.1053\/j.gastro.2009.05.007"},{"issue":"2","key":"9833_CR25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.24418","volume":"54","author":"A Berzigotti","year":"2011","unstructured":"Berzigotti A, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Morillas R, et al. Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology 2011;54(2):555\u2013561","journal-title":"Hepatology"},{"issue":"9865","key":"9833_CR26","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","volume":"381","author":"P Marcellin","year":"2013","unstructured":"Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson IM, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet 2013;381(9865):468\u2013475","journal-title":"Lancet"},{"key":"9833_CR27","first-page":"1","volume":"1","author":"A Berzigotti","year":"2017","unstructured":"Berzigotti A, Villanueva C, Calleja JL, Carlos J, Mesonero F, Bosch J, et al. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study. Hepatology 2017;1:1\u201353","journal-title":"Hepatology"},{"issue":"3","key":"9833_CR28","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/hep.20127","volume":"39","author":"A Monto","year":"2004","unstructured":"Monto A, Patel K, Bostrom A, Pianko S, Pockros P, McHutchison JG, et al. Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology 2004;39(3):826\u2013834","journal-title":"Hepatology"},{"key":"9833_CR29","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1542-3565(05)00407-6","volume":"3","author":"S Hutchinson","year":"2005","unstructured":"Hutchinson S, Bird S, Goldberg D. Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. Clin Gastroenterol Hepatol 2005;3:1150\u20131159","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"9833_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1055\/s-0036-1571295","volume":"36","author":"YJ Yoon","year":"2016","unstructured":"Yoon YJ, Friedman SL, Lee YA. Anti fibrotic therapies: where are we now? Semin Liver Dis 2016;36(1):87\u201398. https:\/\/doi.org\/10.1055\/s-0036-1571295 .","journal-title":"Semin Liver Dis"},{"issue":"4","key":"9833_CR31","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0016-5085(01)81028-3","volume":"121","author":"J Garc\u00eda-Pagan","year":"2001","unstructured":"Garc\u00eda-Pagan J, Villanueva C, Vila M, Albillos A, Genesca J, Ruiz-del-Arbol L, et al. Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers. Gastroenterology 2001;121(4):908\u2013914","journal-title":"Gastroenterology"},{"issue":"6","key":"9833_CR32","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1053\/jhep.2003.50211","volume":"37","author":"JC Garc\u00eda-Pag\u00e1n","year":"2003","unstructured":"Garc\u00eda-Pag\u00e1n JC, Morillas R, Ba\u00f1ares R, Albillos A, Villanueva C, Vila C, et al. Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT. Hepatology 2003;37(6):1260\u20131266","journal-title":"Hepatology"},{"issue":"9","key":"9833_CR33","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/gutjnl-2014-308338","volume":"64","author":"G Marrone","year":"2015","unstructured":"Marrone G, Maeso-D\u00edaz R, Garc\u00eda-Cardena G, Abraldes J, Garc\u00eda-Pag\u00e1n J, Bosch J, et al. KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins. Gut 2015;64(9):1434\u20131443","journal-title":"Gut"},{"issue":"4","key":"9833_CR34","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jhep.2010.04.025","volume":"53","author":"J Trebicka","year":"2010","unstructured":"Trebicka J, Hennenberg M, Odenthal M, Shir K, Klein S, Granzow M, et al. Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells. J Hepatol 2010;53(4):702\u2013712","journal-title":"J Hepatol"},{"key":"9833_CR35","doi-asserted-by":"crossref","unstructured":"Abraldes JG, Albillos A, Ba\u00f1ares R, Turnes J, Gonz\u00e1lez R, Garc\u00eda-Pag\u00e1n JC, et al. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial. Gastroenterology 2009;136(5):1651\u20131658","DOI":"10.1053\/j.gastro.2009.01.043"},{"key":"9833_CR36","doi-asserted-by":"crossref","unstructured":"Mohanty A, Tate JP, Garcia-Tsao G. Statins are associated with a decreased risk of decompensation and death in veterans with hepatitis C-related compensated cirrhosis. Gastroenterology 2016; 150(2): 430e1\u2013440e1","DOI":"10.1053\/j.gastro.2015.10.007"},{"issue":"5","key":"9833_CR37","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1053\/j.gastro.2016.01.004","volume":"150","author":"JG Abraldes","year":"2016","unstructured":"Abraldes JG, Villanueva C, Aracil C, Turnes J, Hernandez-Guerra M, Genesca J, et al. Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis. Gastroenterology 2016;150(5):1160e3\u20131170e3","journal-title":"Gastroenterology"},{"issue":"4","key":"9833_CR38","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0016-5085(95)90586-3","volume":"109","author":"A Albillos","year":"1995","unstructured":"Albillos A, Lled\u00f3 JL, Rossi I, P\u00e9rez-P\u00e1ramo M, Tabuenca MJ, Ba\u00f1ares R, et al. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function. Gastroenterology 1995;109(4):1257\u20131265","journal-title":"Gastroenterology"},{"issue":"1","key":"9833_CR39","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0016-5085(98)70372-5","volume":"115","author":"A Albillos","year":"1998","unstructured":"Albillos A, Garc\u00eda-Pag\u00e1n J, Iborra J, Bandi J, Cacho G, P\u00e9rez-Paramo M, et al. Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension. Gastroenterology 1998;115(1):116\u2013123","journal-title":"Gastroenterology"},{"issue":"6","key":"9833_CR40","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/hep.23689","volume":"51","author":"J Bosch","year":"2010","unstructured":"Bosch J. Carvedilol for portal hypertension in patients with cirrhosis. Hepatology 2010;51(6):2214\u20132218","journal-title":"Hepatology"},{"issue":"6","key":"9833_CR41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/apt.12634","volume":"39","author":"E Sinagra","year":"2014","unstructured":"Sinagra E, Perricone G, D\u2019Amico M, Tin\u00e8 F, D\u2019Amico G. Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis. Aliment Pharmacol Ther 2014;39(6):557\u2013568","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"9833_CR42","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1136\/gutjnl-2012-304038","volume":"62","author":"T Reiberger","year":"2013","unstructured":"Reiberger T, Ulbrich G, Ferlitsch A, Payer BA, Schwabl P, Pinter M, et al. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut 2013;62(11):1634\u20131641","journal-title":"Gut"},{"issue":"2","key":"9833_CR43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/14728214.2016.1184647","volume":"21","author":"H Nair","year":"2016","unstructured":"Nair H, Berzigotti A, Bosch J. Emerging therapies for portal hypertension in cirrhosis. Expert Opin Emerg Drugs 2016;21(2):167\u2013181","journal-title":"Expert Opin Emerg Drugs"},{"key":"9833_CR44","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1053\/j.gastro.2006.12.041","volume":"132","author":"W Laleman","year":"2007","unstructured":"Laleman W, Van Landeghem L, Van der Elst I, Zeegers M, Fevery J, Nevens F. Nitroflurbiprofen, a nitric oxide releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats. Gastroenterology 2007;132:709\u2013719","journal-title":"Gastroenterology"},{"key":"9833_CR45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajpath.2014.10.009","volume":"185","author":"L Verbeke","year":"2015","unstructured":"Verbeke L, Farre R, Verbinnen B, Covens K, Vanuytsel T, Verhaegen J, Komuta M, Roskams T, Chatterjee S, Annaert P, Vander Elst I, Windmolders P, Trebicka J, Nevens F, Laleman W. The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats. Am J Pathol 2015;185:409\u2013419","journal-title":"Am J Pathol"},{"issue":"1","key":"9833_CR46","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/gutjnl-2016-312431","volume":"66","author":"Y Rotman","year":"2017","unstructured":"Rotman Y, Sanyal AJ. Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease. Gut. 2017;66(1):180\u2013190","journal-title":"Gut"},{"issue":"5","key":"9833_CR47","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/hep.25915","volume":"56","author":"EA Tsochatzis","year":"2012","unstructured":"Tsochatzis EA, Bosch J, Burroughs AK. New therapeutic paradigm for patients with cirrhosis. Hepatology 2012;56(5):1983\u20131992","journal-title":"Hepatology"},{"issue":"2","key":"9833_CR48","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/hep.28933","volume":"65","author":"I Zubiete-Franco","year":"2016","unstructured":"Zubiete-Franco I, Fern\u00e1ndez-Tussy P, Barbier-Torres L, Simon J, Fern\u00e1ndez-Ramos D, Lopitz-Otsoa F, et al. Deregulated neddylation in liver fibrosis. Hepatology 2016;65(2):694\u2013709","journal-title":"Hepatology"},{"key":"9833_CR49","doi-asserted-by":"crossref","unstructured":"Villa E, Camm\u00e0 C, Marietta M, Luongo M, Critelli R, Colopi S, et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology 2012; 143(5):1253.e4\u20131260.e4","DOI":"10.1053\/j.gastro.2012.07.018"},{"issue":"1","key":"9833_CR50","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/S0168-8278(17)30455-5","volume":"66","author":"C Villanueva","year":"2017","unstructured":"Villanueva C, Albillos A, Genesc\u00e0 J, Garcia-Pagan J, Calleja J, Aracil C, et al. Preventing the decompensation of cirrhosis with beta-blockers in patients with clinically significant portal hypertension. A multicenter double-blind placebo-controlled randomized clinical trial. J Hepatol. 2017;66(1):S97\u2013S98","journal-title":"J Hepatol"},{"key":"9833_CR51","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/0016-5085(80)90905-1","volume":"79","author":"D Lebrec","year":"1980","unstructured":"Lebrec D, De Fleury P, Rueff B, Nahum H, Benhamou J. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 1980;79:1139\u20131144","journal-title":"Gastroenterology"},{"issue":"3","key":"9833_CR52","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/hep.1840050313","volume":"5","author":"G Garcia-Tsao","year":"1985","unstructured":"Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985;5(3):419\u2013424","journal-title":"Hepatology"},{"issue":"8982","key":"9833_CR53","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(95)91740-3","volume":"346","author":"F Feu","year":"1995","unstructured":"Feu F, Garc\u00eda-Pag\u00e1n JC, Bosch J, Luca A, Escorsell A, Rod\u00e9s J, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995;346(8982):1056\u20131059","journal-title":"Lancet"},{"issue":"5","key":"9833_CR54","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2006.09.013","volume":"131","author":"G D\u2019Amico","year":"2006","unstructured":"D\u2019Amico G, Garcia-Pagan JC, Luca A, Bosch J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 2006;131(5):1611\u20131624","journal-title":"Gastroenterology"},{"key":"9833_CR55","doi-asserted-by":"crossref","unstructured":"Villanueva C, Aracil C, Colomo A, Hern\u00e1ndez-Gea V, L\u00f3pez-Balaguer JM, Alvarez-Urturi C, et al. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding. Gastroenterology 2009; 137(1): 119\u2013128","DOI":"10.1053\/j.gastro.2009.03.048"},{"issue":"3","key":"9833_CR56","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ajg.2011.456","volume":"107","author":"V Hern\u00e1ndez-Gea","year":"2012","unstructured":"Hern\u00e1ndez-Gea V, Aracil C, Colomo A, Garupera I, Poca M, Torras X, et al. Development of ascites in compensated cirrhosis with severe portal hypertension treated with beta-blockers. Am J Gastroenterol 2012;107(3):418\u2013427","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"9833_CR57","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1572-0241.2006.00453.x","volume":"101","author":"J Turnes","year":"2006","unstructured":"Turnes J, Garcia-Pagan JC, Abraldes JG, Hernandez-Guerra M, Dell\u2019Era A, Bosch J. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis. Am J Gastroenterol 2006;101(3):506\u2013512","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"9833_CR58","first-page":"CD004544","volume":"8","author":"LL Gluud","year":"2012","unstructured":"Gluud LL, Krag A. Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults. Cochrane Database Syst Rev 2012;8(8):CD004544","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"9833_CR59","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","volume":"52","author":"T Serst\u00e9","year":"2010","unstructured":"Serst\u00e9 T, Melot C, Francoz C, Durand F, Rautou P-E, Valla D, et al. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology 2010;52(3):1017\u20131022","journal-title":"Hepatology"},{"issue":"3","key":"9833_CR60","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/hep.23164","volume":"50","author":"J Bosch","year":"2009","unstructured":"Bosch J, Garcia-Tsao G. Pharmacological versus endoscopic therapy in the prevention of variceal hemorrhage: and the winner is. Hepatology 2009;50(3):674\u2013677","journal-title":"Hepatology"},{"issue":"3","key":"9833_CR61","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/hep.23045","volume":"50","author":"D Tripathi","year":"2009","unstructured":"Tripathi D, Ferguson JW, Kochar N, Leithead JA, Therapondos G, Mcavoy NC, et al. Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology 2009;50(3):825\u2013833","journal-title":"Hepatology"},{"issue":"4","key":"9833_CR62","first-page":"757","volume":"60","author":"HA Shah","year":"2014","unstructured":"Shah HA, Azam Z, Rauf J, Abid S, Hamid S, Jafri W, et al. Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial. J Hepatol Eur Assoc Study Liver 2014;60(4):757\u2013764","journal-title":"J Hepatol Eur Assoc Study Liver"},{"issue":"1","key":"9833_CR63","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.21945","volume":"47","author":"AV Longacre","year":"2008","unstructured":"Longacre AV, Imaeda A, Garcia-Tsao G, Fraenkel L. A pilot project examining the predicted preferences of patients and physicians in the primary prophylaxis of variceal hemorrhage. Hepatology 2008;47(1):169\u2013176","journal-title":"Hepatology"},{"issue":"4","key":"9833_CR64","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1572-0241.2005.40468.x","volume":"100","author":"SK Sarin","year":"2005","unstructured":"Sarin SK, Wadhawan M, Agarwal SR, Tyagi P, Sharma BC. Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding. Am J Gastroenterol 2005;100(4):797\u2013804","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"9833_CR65","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/j.gastro.2004.05.004","volume":"127","author":"C Merkel","year":"2004","unstructured":"Merkel C, Marin R, Angeli P, Zanella P, Felder M, Bernardinello E, et al. A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology 2004;127(2):476\u2013484","journal-title":"Gastroenterology"},{"key":"9833_CR66","doi-asserted-by":"crossref","unstructured":"Bhardwaj A, Kedarisetty CK, Vashishtha C, Bhadoria AS, Jindal A, Kumar G, et al. Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial. Gut. 2016; gutjnl-2016-311735","DOI":"10.1136\/gutjnl-2016-311735"},{"issue":"1","key":"9833_CR67","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12072-012-9353-8","volume":"7","author":"SK Sarin","year":"2013","unstructured":"Sarin SK, Mishra SR, Sharma P, Sharma BC, Kumar A. Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a randomized controlled trial. Hepatol Int 2013;7(1):248\u2013256","journal-title":"Hepatol Int"},{"issue":"7","key":"9833_CR68","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/00042737-199907000-00011","volume":"11","author":"P Cal\u00e9s","year":"1999","unstructured":"Cal\u00e9s P, Oberti F, Payen J, Naveau S, Guyader D, Blanc P, et al. Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension. Eur J Gastroenterol Hepatol 1999;11(7):741\u2013745","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"9833_CR69","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/liv.12452","volume":"34","author":"A Puente","year":"2014","unstructured":"Puente A, Hern\u00e1ndez-Gea V, Graupera I, Roque M, Colomo A, Poca M, et al. Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review. Liver Int 2014;34(6):823\u2013833","journal-title":"Liver Int"},{"issue":"7","key":"9833_CR70","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1365-2036.2010.04418.x","volume":"32","author":"LL Gluud","year":"2010","unstructured":"Gluud LL, Langholz E, Krag A. Meta-analysis: isosorbide-mononitrate alone or with either beta-blockers or endoscopic therapy for the management of oesophageal varices. Aliment Pharmacol Ther 2010;32(7):859\u2013871","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"9833_CR71","first-page":"1014","volume":"61","author":"AJ Stanley","year":"2014","unstructured":"Stanley AJ, Dickson S, Hayes PC, Forrest EH, Mills PR, Tripathi D, et al. Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding. J Hepatol Eur Assoc Study Liver 2014;61(5):1014\u20131019","journal-title":"J Hepatol Eur Assoc Study Liver"},{"issue":"11","key":"9833_CR72","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1440-1746.2012.07244.x","volume":"27","author":"GH Lo","year":"2012","unstructured":"Lo GH, Chen WC, Wang HM, Yu HC. Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding. J Gastroenterol Hepatol 2012;27(11):1681\u20131687","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"9833_CR73","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.23383","volume":"51","author":"TD Boyer","year":"2010","unstructured":"Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009. Hepatology 2010;51(1):306","journal-title":"Hepatology"},{"issue":"2","key":"9833_CR74","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hep.28318","volume":"63","author":"IL Holster","year":"2016","unstructured":"Holster IL, Tjwa ETTL, Moelker A, Wils A, Hansen BE, Vermeijden JR, et al. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy\u00a0+\u00a0beta-blocker for prevention of variceal rebleeding. Hepatology 2016;63(2):581\u2013589","journal-title":"Hepatology"},{"issue":"6","key":"9833_CR75","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/hep.1840160607","volume":"16","author":"SK Sarin","year":"1992","unstructured":"Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992;16(6):1343\u20131349","journal-title":"Hepatology"},{"issue":"6","key":"9833_CR76","first-page":"1161","volume":"54","author":"SR Mishra","year":"2011","unstructured":"Mishra SR, Sharma BC, Kumar A, Sarin SK. Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial. J Hepatol Eur Assoc Study Liver 2011;54(6):1161\u20131167","journal-title":"J Hepatol Eur Assoc Study Liver"},{"issue":"6","key":"9833_CR77","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/gut.2009.192039","volume":"59","author":"SR Mishra","year":"2010","unstructured":"Mishra SR, Chander Sharma B, Kumar A, Sarin SK. Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial. Gut 2010;59(6):729\u2013735","journal-title":"Gut"},{"issue":"5","key":"9833_CR78","first-page":"1025","volume":"56","author":"HH Hung","year":"2012","unstructured":"Hung HH, Chang CJ, Hou MC, Liao WC, Chan CC, Huang HC, et al. Efficacy of non-selective \u03b2-blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding: a randomized controlled trial. J Hepatol Eur Assoc Study Liver 2012;56(5):1025\u20131032","journal-title":"J Hepatol Eur Assoc Study Liver"},{"key":"9833_CR79","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1055\/s-2007-966591","volume":"39","author":"G Lo","year":"2007","unstructured":"Lo G, Liang H, Chen W, Lai K, Hsu P, Lin C, et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy 2007;39:679\u2013685","journal-title":"Endoscopy"},{"issue":"3","key":"9833_CR80","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1051-0443(07)61912-5","volume":"12","author":"T Fukuda","year":"2001","unstructured":"Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol 2001;12(3):327\u2013336","journal-title":"J Vasc Interv Radiol"},{"key":"9833_CR81","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cld.2014.07.005","volume":"18","author":"W Saad","year":"2014","unstructured":"Saad W. Endovascular management of gastric varices. Clin Liver Dis 2014;18:829\u2013851","journal-title":"Clin Liver Dis"},{"issue":"2","key":"9833_CR82","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1055\/s-0032-1312573","volume":"29","author":"W Saad","year":"2012","unstructured":"Saad W. Balloon-occluded retrograde transvenous obliteration of gastric varices: concept, basic techniques, and outcomes. Semin Intervent Radiol 2012;29(2):118\u2013128","journal-title":"Semin Intervent Radiol"},{"issue":"4","key":"9833_CR83","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2011.01.034","volume":"55","author":"T Serst\u00e9","year":"2011","unstructured":"Serst\u00e9 T, Francoz C, Durand F, Rautou PE, Melot C, Valla D, et al. Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study. J Hepatol 2011;55(4):794\u2013799","journal-title":"J Hepatol"},{"issue":"7","key":"9833_CR84","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1053\/j.gastro.2014.03.005","volume":"146","author":"M Mandorfer","year":"2014","unstructured":"Mandorfer M, Bota S, Schwabl P, Bucsics T, Pfisterer N, Kruzik M, et al. Nonselective beta-blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis. Gastroenterology 2014;146(7):1680\u20131690","journal-title":"Gastroenterology"},{"issue":"7","key":"9833_CR85","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/gutjnl-2013-306502","volume":"64","author":"JA Leithead","year":"2015","unstructured":"Leithead JA, Rajoriya N, Tehami N, Hodson J, Gunson BK, Tripathi D, et al. Non-selective beta-blockers are associated with improved survival in patients with ascites listed for liver transplantation. Gut 2015;64(7):1111\u20131119","journal-title":"Gut"},{"issue":"6","key":"9833_CR86","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/hep.28352","volume":"63","author":"L Bossen","year":"2016","unstructured":"Bossen L, Krag A, Vilstrup H, Watson H, Jepsen P. Nonselective beta-blockers do not affect mortality in cirrhosis patients with ascites: post hoc analysis of three randomized controlled trials with 1198 patients. Hepatology 2016;63(6):1968\u20131976","journal-title":"Hepatology"},{"key":"9833_CR87","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/liv.13119","volume":"36","author":"UC Bang","year":"2016","unstructured":"Bang UC, Benfield T, Hyldstrup L, Jensen J-EB, Bendtsen F. Effect of propranolol on survival in patients with decompensated cirrhosis: a nationwide study based Danish patient registers. Liver Int 2016;36:1304\u20131312","journal-title":"Liver Int"},{"issue":"3","key":"9833_CR88","first-page":"574","volume":"64","author":"RP Mookerjee","year":"2016","unstructured":"Mookerjee RP, Pavesi M, Thomsen KL, Mehta G, MacNaughtan J, Bendtsen F, et al. Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure. J Hepatol Eur Assoc Study Liver 2016;64(3):574\u2013582","journal-title":"J Hepatol Eur Assoc Study Liver"},{"key":"9833_CR89","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jhep.2016.01.031","volume":"64","author":"B Madsen","year":"2016","unstructured":"Madsen B, Nielsen K, Fialla A, Krag A. Keep the sick from harm in spontaneous bacterial peritonitis: dose of beta blockers matters. J Hepatol 2016;64:1455\u20131456","journal-title":"J Hepatol"},{"key":"9833_CR90","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/hep.1840070306","volume":"7","author":"T Poynard","year":"1987","unstructured":"Poynard T, Lebrec D, Hillon P, Sayegh R, Bernuau J, Naveau S, et al. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a prospective study of factors associated with rebleeding. Hepatology 1987;7:447\u2013451","journal-title":"Hepatology"},{"key":"9833_CR91","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/MCG.0b013e318256b670","volume":"46","author":"A Singal","year":"2012","unstructured":"Singal A, Jampana S, Singal V, Kuo Y. Hepatocellular carcinoma predicts in-hospital mortality from acute variceal hemorrhage among patients with cirrhosis. J Clin Gastroenterol 2012;46:613\u2013619","journal-title":"J Clin Gastroenterol"},{"key":"9833_CR92","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/hep.26629","volume":"58","author":"C Ripoll","year":"2013","unstructured":"Ripoll C, Genesc\u00e0 J, Araujo I, Graupera I, Augustin S, Tejedor M, et al. Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control study. Hepatology 2013;58:2079\u20132088","journal-title":"Hepatology"},{"key":"9833_CR93","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cgh.2012.02.011","volume":"10","author":"A Souza De","year":"2012","unstructured":"De Souza A, La Mura V, Reverter E, Seijo S, Berzigotti A, Ashkenazi E, et al. Patients whose first episode of bleeding occurs while taking a betablocker have high long-term risks of rebleeding and death. Clin Gastroenterol Hepatol 2012;10:670\u2013676","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-017-9833-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-017-9833-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-017-9833-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T08:22:34Z","timestamp":1570436554000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-017-9833-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,5]]},"references-count":93,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["9833"],"URL":"https:\/\/doi.org\/10.1007\/s12072-017-9833-y","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,5]]}}}